Zhi Liang Wu
About Zhi Liang Wu
Zhi Liang Wu is a Technology Transfer Scientist at the National Institutes of Health, with over 17 years of experience in preclinical drug discovery and development. He has held various scientific roles at organizations such as Cephalon and The Children's Hospital of Philadelphia, and he has a strong background in translational neuroscience and project management.
Work at National Institutes of Health
Zhi Liang Wu has been employed at the National Institutes of Health (NIH) as a Technology Transfer Scientist since 2013. In this role, he focuses on facilitating the transfer of technology developed within the NIH to the commercial sector. His work contributes to the advancement of biomedical research and the development of new therapies. Wu's tenure at NIH has lasted for over 11 years, during which he has engaged in various initiatives aimed at enhancing the impact of research findings on public health.
Previous Experience at Cephalon
Wu held multiple positions at Cephalon, a biopharmaceutical company, from 1999 to 2009. He began as a Research Scientist II from 1999 to 2001, followed by a promotion to Research Scientist III from 2002 to 2004, and ultimately served as a Senior Scientist I from 2005 to 2009. His roles involved significant contributions to drug discovery and development processes, leveraging his expertise in pharmacology and biology.
Experience at The Children's Hospital of Philadelphia
From 2010 to 2013, Wu worked as a Senior Scientist II at The Children's Hospital of Philadelphia. In this capacity, he contributed to research initiatives focused on pediatric health, utilizing his background in pharmacology and molecular biology. This position further enhanced his experience in translational neuroscience and project management within a clinical research setting.
Educational Background
Wu has a comprehensive educational background in the life sciences. He earned a Bachelor of Science in Biology from Wuhan University from 1980 to 1984. He then pursued advanced studies at the Chinese Academy of Sciences Shanghai Branch, obtaining a Doctor of Philosophy in Molecular Biology from 1984 to 1989. Wu continued his education at the University of Washington - School of Medicine, where he studied Biology and Pharmacology from 1990 to 1995. He furthered his training at the University of California, San Francisco - School of Medicine, specializing in Pharmacology from 1995 to 1997.
Expertise in Preclinical Drug Discovery
Zhi Liang Wu possesses 17 years of experience in preclinical drug discovery and development. His expertise encompasses various aspects of the drug development process, including translational neuroscience, which focuses on the application of laboratory research to clinical settings. Wu's strong background in project management enhances his ability to lead and coordinate research initiatives effectively.